Loading…
Purple Biosciences, LLC, a dietary supplement company, received an FDA Warning Letter on July 23, 2020, though the specific violations cannot be detailed as the full letter text is not available. Based on limited metadata alone, the nature of the regulatory concerns cannot be accurately determined. The warning falls under FDA oversight of dietary supplements, though the specific issuing office is unknown. To understand the exact compliance issues and required corrective actions, review of the complete Warning Letter text would be necessary.